Vivos Therapeutics (VVOS) Competitors

Vivos Therapeutics logo
$0.06 0.00 (-1.76%)
As of 09:30 AM Eastern
This is a fair market value price provided by Massive. Learn more.

VVOS vs. INBS, BDMD, TNON, NVNO, and AEMD

Should you buy Vivos Therapeutics stock or one of its competitors? Vivos Therapeutics's main competitors and comparable companies include Intelligent Bio Solutions (INBS), Baird Medical Investment (BDMD), Tenon Medical (TNON), enVVeno Medical (NVNO), and Aethlon Medical (AEMD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Vivos Therapeutics compare to Intelligent Bio Solutions?

Vivos Therapeutics (NASDAQ:VVOS) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability, risk and media sentiment.

In the previous week, Vivos Therapeutics had 7 more articles in the media than Intelligent Bio Solutions. MarketBeat recorded 7 mentions for Vivos Therapeutics and 0 mentions for Intelligent Bio Solutions. Vivos Therapeutics' average media sentiment score of 0.74 beat Intelligent Bio Solutions' score of 0.44 indicating that Vivos Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
Vivos Therapeutics Positive
Intelligent Bio Solutions Neutral

26.4% of Vivos Therapeutics shares are held by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are held by institutional investors. 1.4% of Vivos Therapeutics shares are held by insiders. Comparatively, 2.8% of Intelligent Bio Solutions shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Intelligent Bio Solutions has lower revenue, but higher earnings than Vivos Therapeutics. Intelligent Bio Solutions is trading at a lower price-to-earnings ratio than Vivos Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vivos Therapeutics$17.44M0.07-$21.17M-$1.48N/A
Intelligent Bio Solutions$4.22M1.19-$12.43M-$6.38N/A

Vivos Therapeutics has a beta of 6.37, indicating that its share price is 537% more volatile than the broader market. Comparatively, Intelligent Bio Solutions has a beta of 4.48, indicating that its share price is 348% more volatile than the broader market.

Vivos Therapeutics currently has a consensus price target of $2.80, indicating a potential upside of 4,820.91%. Given Vivos Therapeutics' stronger consensus rating and higher probable upside, equities analysts plainly believe Vivos Therapeutics is more favorable than Intelligent Bio Solutions.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vivos Therapeutics
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Intelligent Bio Solutions
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Vivos Therapeutics has a net margin of -107.36% compared to Intelligent Bio Solutions' net margin of -269.28%. Intelligent Bio Solutions' return on equity of -150.00% beat Vivos Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Vivos Therapeutics-107.36% -2,325.64% -90.72%
Intelligent Bio Solutions -269.28%-150.00%-83.38%

Summary

Vivos Therapeutics beats Intelligent Bio Solutions on 10 of the 16 factors compared between the two stocks.

How does Vivos Therapeutics compare to Baird Medical Investment?

Vivos Therapeutics (NASDAQ:VVOS) and Baird Medical Investment (NASDAQ:BDMD) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, earnings, profitability, valuation, dividends and risk.

Vivos Therapeutics has a beta of 6.37, suggesting that its share price is 537% more volatile than the broader market. Comparatively, Baird Medical Investment has a beta of -0.98, suggesting that its share price is 198% less volatile than the broader market.

Baird Medical Investment has higher revenue and earnings than Vivos Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vivos Therapeutics$17.44M0.07-$21.17M-$1.48N/A
Baird Medical Investment$22.54M0.19N/AN/AN/A

Baird Medical Investment has a net margin of 0.00% compared to Vivos Therapeutics' net margin of -107.36%. Baird Medical Investment's return on equity of 0.00% beat Vivos Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Vivos Therapeutics-107.36% -2,325.64% -90.72%
Baird Medical Investment N/A N/A N/A

Vivos Therapeutics presently has a consensus target price of $2.80, indicating a potential upside of 4,820.91%. Given Vivos Therapeutics' stronger consensus rating and higher possible upside, equities analysts clearly believe Vivos Therapeutics is more favorable than Baird Medical Investment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vivos Therapeutics
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Baird Medical Investment
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

26.4% of Vivos Therapeutics shares are owned by institutional investors. Comparatively, 19.8% of Baird Medical Investment shares are owned by institutional investors. 1.4% of Vivos Therapeutics shares are owned by insiders. Comparatively, 78.9% of Baird Medical Investment shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Vivos Therapeutics had 6 more articles in the media than Baird Medical Investment. MarketBeat recorded 7 mentions for Vivos Therapeutics and 1 mentions for Baird Medical Investment. Vivos Therapeutics' average media sentiment score of 0.74 beat Baird Medical Investment's score of 0.17 indicating that Vivos Therapeutics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Vivos Therapeutics
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Baird Medical Investment
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Vivos Therapeutics beats Baird Medical Investment on 7 of the 13 factors compared between the two stocks.

How does Vivos Therapeutics compare to Tenon Medical?

Vivos Therapeutics (NASDAQ:VVOS) and Tenon Medical (NASDAQ:TNON) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk, media sentiment and valuation.

Tenon Medical has lower revenue, but higher earnings than Vivos Therapeutics. Vivos Therapeutics is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vivos Therapeutics$17.44M0.07-$21.17M-$1.48N/A
Tenon Medical$3.94M0.67-$12.56M-$36.27N/A

In the previous week, Vivos Therapeutics had 5 more articles in the media than Tenon Medical. MarketBeat recorded 7 mentions for Vivos Therapeutics and 2 mentions for Tenon Medical. Vivos Therapeutics' average media sentiment score of 0.74 beat Tenon Medical's score of -0.27 indicating that Vivos Therapeutics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Vivos Therapeutics
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Tenon Medical
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Vivos Therapeutics currently has a consensus price target of $2.80, indicating a potential upside of 4,820.91%. Given Vivos Therapeutics' stronger consensus rating and higher possible upside, equities research analysts plainly believe Vivos Therapeutics is more favorable than Tenon Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vivos Therapeutics
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Tenon Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Vivos Therapeutics has a net margin of -107.36% compared to Tenon Medical's net margin of -305.10%. Vivos Therapeutics' return on equity of -2,325.64% beat Tenon Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Vivos Therapeutics-107.36% -2,325.64% -90.72%
Tenon Medical -305.10%-3,216.08%-136.74%

26.4% of Vivos Therapeutics shares are owned by institutional investors. Comparatively, 22.7% of Tenon Medical shares are owned by institutional investors. 1.4% of Vivos Therapeutics shares are owned by company insiders. Comparatively, 17.7% of Tenon Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Vivos Therapeutics has a beta of 6.37, suggesting that its stock price is 537% more volatile than the broader market. Comparatively, Tenon Medical has a beta of 1.43, suggesting that its stock price is 43% more volatile than the broader market.

Summary

Vivos Therapeutics beats Tenon Medical on 12 of the 16 factors compared between the two stocks.

How does Vivos Therapeutics compare to enVVeno Medical?

Vivos Therapeutics (NASDAQ:VVOS) and enVVeno Medical (NASDAQ:NVNO) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, risk, valuation, institutional ownership, media sentiment, profitability and dividends.

26.4% of Vivos Therapeutics shares are held by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are held by institutional investors. 1.4% of Vivos Therapeutics shares are held by company insiders. Comparatively, 14.8% of enVVeno Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

enVVeno Medical has a net margin of 0.00% compared to Vivos Therapeutics' net margin of -107.36%. enVVeno Medical's return on equity of -70.33% beat Vivos Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Vivos Therapeutics-107.36% -2,325.64% -90.72%
enVVeno Medical N/A -70.33%-63.60%

Vivos Therapeutics currently has a consensus price target of $2.80, suggesting a potential upside of 4,820.91%. Given Vivos Therapeutics' higher possible upside, research analysts clearly believe Vivos Therapeutics is more favorable than enVVeno Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vivos Therapeutics
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
enVVeno Medical
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.33

Vivos Therapeutics has a beta of 6.37, meaning that its share price is 537% more volatile than the broader market. Comparatively, enVVeno Medical has a beta of 1.4, meaning that its share price is 40% more volatile than the broader market.

In the previous week, Vivos Therapeutics had 7 more articles in the media than enVVeno Medical. MarketBeat recorded 7 mentions for Vivos Therapeutics and 0 mentions for enVVeno Medical. Vivos Therapeutics' average media sentiment score of 0.74 beat enVVeno Medical's score of 0.00 indicating that Vivos Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
Vivos Therapeutics Positive
enVVeno Medical Neutral

enVVeno Medical has lower revenue, but higher earnings than Vivos Therapeutics. enVVeno Medical is trading at a lower price-to-earnings ratio than Vivos Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vivos Therapeutics$17.44M0.07-$21.17M-$1.48N/A
enVVeno MedicalN/AN/A-$19.47M-$17.55N/A

Summary

Vivos Therapeutics and enVVeno Medical tied by winning 8 of the 16 factors compared between the two stocks.

How does Vivos Therapeutics compare to Aethlon Medical?

Aethlon Medical (NASDAQ:AEMD) and Vivos Therapeutics (NASDAQ:VVOS) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends, media sentiment and valuation.

Aethlon Medical has a net margin of 0.00% compared to Vivos Therapeutics' net margin of -107.36%. Aethlon Medical's return on equity of -141.23% beat Vivos Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Aethlon MedicalN/A -141.23% -115.44%
Vivos Therapeutics -107.36%-2,325.64%-90.72%

Aethlon Medical has higher earnings, but lower revenue than Vivos Therapeutics. Aethlon Medical is trading at a lower price-to-earnings ratio than Vivos Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aethlon MedicalN/AN/A-$7.15M-$18.87N/A
Vivos Therapeutics$17.44M0.07-$21.17M-$1.48N/A

In the previous week, Vivos Therapeutics had 7 more articles in the media than Aethlon Medical. MarketBeat recorded 7 mentions for Vivos Therapeutics and 0 mentions for Aethlon Medical. Aethlon Medical's average media sentiment score of 1.50 beat Vivos Therapeutics' score of 0.74 indicating that Aethlon Medical is being referred to more favorably in the media.

Company Overall Sentiment
Aethlon Medical Very Positive
Vivos Therapeutics Positive

Aethlon Medical currently has a consensus target price of $1.50, indicating a potential downside of 69.01%. Vivos Therapeutics has a consensus target price of $2.80, indicating a potential upside of 4,820.91%. Given Vivos Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Vivos Therapeutics is more favorable than Aethlon Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aethlon Medical
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Vivos Therapeutics
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

2.0% of Aethlon Medical shares are held by institutional investors. Comparatively, 26.4% of Vivos Therapeutics shares are held by institutional investors. 0.6% of Aethlon Medical shares are held by company insiders. Comparatively, 1.4% of Vivos Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Aethlon Medical has a beta of 1.27, indicating that its share price is 27% more volatile than the broader market. Comparatively, Vivos Therapeutics has a beta of 6.37, indicating that its share price is 537% more volatile than the broader market.

Summary

Vivos Therapeutics beats Aethlon Medical on 10 of the 14 factors compared between the two stocks.

Get Vivos Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for VVOS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VVOS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VVOS vs. The Competition

MetricVivos TherapeuticsHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1.09M$5.92B$7.57B$11.65B
Dividend YieldN/A1.69%2.48%4.74%
P/E Ratio-0.0438.9333.0728.17
Price / Sales0.065.308.295.46
Price / CashN/A23.4220.7221.66
Price / Book-0.804.154.423.65
Net Income-$21.17M$143.14M$3.51B$394.00M
7 Day PerformanceN/A-4.71%-5.54%-5.64%
1 Month PerformanceN/A-6.71%-8.71%-9.48%
1 Year PerformanceN/A-1.06%-1.46%-6.81%

Vivos Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VVOS
Vivos Therapeutics
2.252 of 5 stars
$0.06
-1.8%
$2.80
+4,908.9%
-97.6%$1.09M$17.44MN/A268
INBS
Intelligent Bio Solutions
1.2253 of 5 stars
$2.08
-7.5%
N/A-78.0%$6.99M$4.22MN/A60
BDMD
Baird Medical Investment
1.1126 of 5 stars
$0.11
+17.5%
N/A-92.4%$4.85M$22.54MN/A146
TNON
Tenon Medical
1.0129 of 5 stars
$1.80
+3.4%
N/A-97.5%$4.84M$3.94MN/A26
NVNO
enVVeno Medical
1.2502 of 5 stars
$6.48
+0.5%
N/A-49.7%$4.54MN/AN/A33

Related Companies and Tools


This page (NASDAQ:VVOS) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners